Bracco/Acist completes E-Z-EM purchase
This article was originally published in The Gray Sheet
Executive Summary
Acquisition of gastrointestinal tract imaging contrast media and administration kit maker E-Z-EM by Italian firm Bracco/Acist for $241 million is completed April 1. First announced Oct. 30, 2007, the deal includes Lake Success, N.Y.-based E-Z-EM's Empower line of contrast injector delivery systems, IRiS contrast management system and the EZ Chem point-of-care blood analyzer for testing serum creatinine levels. The E-Z-EM offerings complement Bracco/Acist's contrast delivery systems and diagnostic imaging agents, according to the company